In conversation at DIA Europe 2023 in Basel, European Medicines Agency Executive Director Emer Cooke looks back at the lessons EMA has taken from the COVID-19 pandemic response, outlines the Agency’s approach to antimicrobial resistance, and highlights how it hopes to contribute to a stronger European clinical trials ecosystem.
As regulators, we have a great opportunity to build on the COVID experience and make sure that we are part of an ecosystem that brings new products which can make a difference for patients
